Hyperfine HYPR
NASDAQ HYPR
$0.89 -0.01 (-1.61%)
At close: Aug 20, 2026 · 2:35 PM UTC

Hyperfine (HYPR) Gains from Investment Securities (2025 - 2026)

Hyperfine's (HYPR) quarterly Gains from Investment Securities came in at $241000.0 in Q1 2026, up 114.89% YoY from $112147.8 in Q1 2025, and up 116.46% on a QoQ basis from -$1.5 million in Q4 2025.

Hyperfine (HYPR) Gains from Investment Securities (2025 - 2026) Analysis & Trends

Hyperfine (HYPR) has 2 years of Gains from Investment Securities data on file, last reported at $241000.0 in Q1 2026.

  • Quarterly Gains from Investment Securities rose 114.89% year-over-year to $241000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 163.91% YoY) and the FY2025 annual result came in at -$825000.0, changed N/A from the prior year.
  • Gains from Investment Securities grew to $241000.0 in Q1 2026, from -$1.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.3 million in Q3 2025 to a low of -$1.6 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn
10 Hyperfine 88.57 Mn 43.81 Mn 1.98 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 571,000.00
Jun 30, 2026 571,000.00
Mar 31, 2026 241,000.00
Mar 31, 2026 241,000.00
Dec 31, 2025 -1.46 Mn
Dec 31, 2025 -1.46 Mn
Sep 30, 2025 2.30 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 -46,000.00
Jun 30, 2025 -46,000.00
Mar 31, 2025 -1.62 Mn
Mar 31, 2025 -1.62 Mn